LPA and cardiovascular disorder: A meta-analysis of 29,069 patients, including 8064 women, with repeat Lp(a) measurements, found a linear association between both baseline and on-statin Lp(a) levels and cardiovascular disease risk, with an increased risk observed at Lp(a) levels of 30 mg/dL or higher for baseline and 50 mg/dL or higher for on-statin Lp(a) [28].